http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0111607-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38214d2b61566e8b243556d174e623c6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-12 |
| filingDate | 1982-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53fbcde673210df7648ca3fdfb68f408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09cac18139996a0fb6017821dfa7d214 |
| publicationDate | 1984-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0111607-A1 |
| titleOfInvention | Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment |
| abstract | Migraine is treated with a pseudotropyl or tropyl benzoate derivative of the following general Formula 1;-n wherein:-Ar representsn n n represents 0 or an integer from 1 to 3 R 1 represents C 1 -C 4 alkyl; R z represents C 1 -C 4 alkyl. C 1 -C 4 alkoxy or halogen provided that R 2 is the same as R, when n is 2 or 3: and R 3 and R 4 independently represent hydrogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, or halogen provided that for tropyl derivatives R 3 is alkyl and R 4 is hydrogen: or a pharmaceutically acceptable salt thereof. n With the exception of tropyl-2-methylbenzoate, the derivatives of Formula I are novel compounds. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4910207-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5017582-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100742008-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4803199-A |
| priorityDate | 1982-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 258.